Literature DB >> 19003277

Estrogen directly down-regulates the bone-resorbing activity of mature osteoclasts through nuclear estrogen receptor alpha.

H Mano1, Y Hakeda, M Kumegawa.   

Abstract

The decrease in estrogen level that follows the onset ofmenopause causes rapid bone loss, resulting in osteoporosis.However, the mechanism remains unclear, especially concerningthe regulation of bone-resorbing osteoclasts. Here we analyzedthe function of estrogen and its receptor in matureosteoclasts. We found that estrogen directly inhibitedbone-resorption by purified rabbit mature-osteoclasts.Moreover, using a RT-PCR technique, we report that nuclearestrogen receptor (ER) alpha but not ERbeta is expressed in mature osteoclasts. The antisense oligodeoxynucleotide for ERalpha inhibited the reductionin osteoclastic bone-resorbing activity caused by estrogen. We conclude that in part estrogen directly inhibits the bone-resorbing activity of mature osteoclasts through the ERalpha.

Entities:  

Year:  2001        PMID: 19003277      PMCID: PMC3466614          DOI: 10.1023/A:1008188120766

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  18 in total

1.  Expression of estrogen receptor beta in rat bone.

Authors:  Y Onoe; C Miyaura; H Ohta; S Nozawa; T Suda
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

2.  Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells.

Authors:  J Arts; G G Kuiper; J M Janssen; J A Gustafsson; C W Löwik; H A Pols; J P van Leeuwen
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

3.  Cloning of a novel receptor expressed in rat prostate and ovary.

Authors:  G G Kuiper; E Enmark; M Pelto-Huikko; S Nilsson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.

Authors:  G G Kuiper; B Carlsson; K Grandien; E Enmark; J Häggblad; S Nilsson; J A Gustafsson
Journal:  Endocrinology       Date:  1997-03       Impact factor: 4.736

5.  Estrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathway.

Authors:  S K Das; J A Taylor; K S Korach; B C Paria; S K Dey; D B Lubahn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning.

Authors:  T Yoshizawa; Y Handa; Y Uematsu; S Takeda; K Sekine; Y Yoshihara; T Kawakami; K Arioka; H Sato; Y Uchiyama; S Masushige; A Fukamizu; T Matsumoto; S Kato
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

7.  A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells.

Authors:  Y Takada; M Kusuda; K Hiura; T Sato; H Mochizuki; Y Nagao; M Tomura; M Yahiro; Y Hakeda; H Kawashima
Journal:  Bone Miner       Date:  1992-06

8.  Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta.

Authors:  B Stein; M X Yang
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

9.  Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance.

Authors:  N N Yang; H U Bryant; S Hardikar; M Sato; R J Galvin; A L Glasebrook; J D Termine
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736

10.  Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts.

Authors:  T Kameda; H Mano; T Yuasa; Y Mori; K Miyazawa; M Shiokawa; Y Nakamaru; E Hiroi; K Hiura; A Kameda; N N Yang; Y Hakeda; M Kumegawa
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

View more
  4 in total

1.  Estrogen receptor α (ESR1) IVS1-397T>C polymorphism lowers risk of fracture.

Authors:  Jian Wang; Gang Feng; Hang Li; Weixu Li; Zhijun Pan; Jianwei Wang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Proteomic Analysis of Estrogen-Mediated Signal Transduction in Osteoclasts Formation.

Authors:  Qi Xiong; Peifu Tang; Yanpan Gao; Lihai Zhang; Wei Ge
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

3.  Mangiferin positively regulates osteoblast differentiation and suppresses osteoclast differentiation.

Authors:  Yuusuke Sekiguchi; Hiroshi Mano; Sachie Nakatani; Jun Shimizu; Aya Kataoka; Kana Ogura; Yoshifumi Kimira; Midori Ebata; Masahiro Wada
Journal:  Mol Med Rep       Date:  2017-06-12       Impact factor: 2.952

4.  Fructus Ligustri Lucidi modulates estrogen receptor expression with no uterotrophic effect in ovariectomized rats.

Authors:  Yu-Qing Tang; Cheng Li; Xue-Jiao Sun; Yi Liu; Xi-Ting Wang; Yu-Bo Guo; Li-Li Wang; Ru-Feng Ma; Jian-Zhao Niu; Min Fu; Dong-Wei Zhang; Yu Li
Journal:  BMC Complement Altern Med       Date:  2018-04-02       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.